Ignite Creation Date:
2024-05-05 @ 11:12 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01276847
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2011-01-12
Brief Title:
A Study to Assess the Effect of Ustekinumab Stelara and Etanercept Enbrel in Participants With Moderate to Severe Psoriasis MK-0000-206
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC